Osaic Holdings’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10K Sell
2,200
-11,700
-84% -$40.5K ﹤0.01% 6292
2025
Q4
$27.9K Sell
13,900
-4
-0% -$8 ﹤0.01% 5633
2025
Q3
$23.7K Buy
13,904
+4
+0% +$5 ﹤0.01% 5822
2025
Q2
$13.1K Sell
13,900
-11,505
-45% -$10.7K ﹤0.01% 5993
2025
Q1
$24.9K Buy
25,405
+11,505
+83% +$12.9K ﹤0.01% 5203
2024
Q4
$16.5K Sell
13,900
-5
-0% -$6 ﹤0.01% 5471
2024
Q3
$18.2K Sell
13,905
-7,650
-35% -$11.8K ﹤0.01% 5440
2024
Q2
$33K Buy
21,555
+5,046
+31% +$8.72K ﹤0.01% 4996
2024
Q1
$33.2K Sell
16,509
-800
-5% -$2.03K ﹤0.01% 5027
2023
Q4
$52.1K Sell
17,309
-4,225
-20% -$12.5K ﹤0.01% 4879
2023
Q3
$72.1K Sell
21,534
-11,235
-34% -$45.1K ﹤0.01% 4745
2023
Q2
$142K Buy
32,769
+32,748
+155,943% +$155K ﹤0.01% 4167
2023
Q1
$79 Sell
21
-3,500
-99% -$12.6K ﹤0.01% 7351
2022
Q4
$12K Buy
3,521
+3,473
+7,235% +$9.14K ﹤0.01% 5863
2022
Q3
$0 Sell
48
-8,723
-99% -$18.8K ﹤0.01% 7556
2022
Q2
$17K Buy
8,771
+8,750
+41,667% +$19.9K ﹤0.01% 5738
2022
Q1
$0 Sell
21
-4,500
-100% -$15.4K ﹤0.01% 7554
2021
Q4
$17K Buy
4,521
+4,100
+974% +$16.4K ﹤0.01% 5917
2021
Q3
$2K Buy
421
+400
+1,905% +$1.84K ﹤0.01% 6902
2021
Q2
$0 Hold
21
﹤0.01% 7158
2021
Q1
$0 Buy
21
+4
+24% +$37 ﹤0.01% 6975
2020
Q4
$0 Sell
17
-1
-6% -$7 ﹤0.01% 6613
2020
Q3
$0 Hold
18
﹤0.01% 6449
2020
Q2
$0 Hold
18
﹤0.01% 6376
2020
Q1
$0 Buy
+18
New +$156 ﹤0.01% 6213

Other funds holding IRD

Osaic Holdings's IRD Position: Q1 2026 in Review

Osaic Holdings reduced its Opus Genetics (IRD) stake by 84% in Q1 2026, selling an estimated $40.5K and leaving 2,200 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #6292.

Osaic Holdings first reported a position in IRD in Q1 2020 and has held it in 25 quarters since. The position peaked at $142K in Q2 2023. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Osaic Holdings held 2,200 shares of Opus Genetics worth $10K as of Q1 2026.
  • Osaic Holdings sold 11,700 Opus Genetics shares in Q1 2026, an estimated $40.5K.
  • Opus Genetics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6292 holding.
  • Osaic Holdings first reported a position in Opus Genetics in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Opus Genetics position peaked at $142K in Q2 2023.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.